冠状动脉疾病的抗炎疗法:我们站在哪里?
Jelena Rakocevic1, Milan Dobric2,3, Milica Labudovic Borovic1
1Institute of Histology and Embryology "Aleksandar Đ. Kostić", Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Reviews in cardiovascular medicine
|July 30, 2024
概括
炎症是动脉样硬化的关键. 准炎症通路,比如NLRP3炎症酶,显示出新疗法减少心血管风险的前景,超出目前的疗法.
科学领域:
- 心血管医学 心血管医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化病原包括胆固醇和炎症之间的复杂相互作用,免疫细胞发挥着重要作用.
- 尽管进行了最佳的医疗治疗,心血管疾病仍然是导致死亡的主要原因,这凸显了对新策略的需求.
- 剩余的心血管风险需要创新的方法,特别是针对动脉样硬化心血管疾病中的炎症.
研究的目的:
- 提供炎症在动脉样硬化中的作用的概述.
- 确定主要的炎症标志物和抗炎疗法向的通路.
- 在动脉样硬化心血管疾病中批判性审查抗炎药物的临床试验.
主要方法:
- 对动脉样硬化和炎症的实验和临床研究的审查.
- 分析各种抗炎药物,包括宽谱药物和向单克隆抗体.
- 评估评估非向和向抗炎药物的临床试验.
主要成果:
- 胆固醇和向NOD,LRR和pyrin域含有蛋白3 (NLRP3) 炎症酶/介质素-1β (IL-1β) /介质素-6 (IL-6) /C反应蛋白 (CRP) 途径显示出有希望的结果.
- 目前没有专门批准用于冠状动脉疾病炎症的抗炎药物.
- 目前正在进行的研究表明,抗炎疗法可能是动脉样硬化心血管疾病的额外策略.
结论:
- 炎症是动脉样硬化各个阶段的关键组成部分.
- 针对特定的炎症途径,如NLRP3炎症酶,代表了一个有前途的治疗途径.
- 抗炎疗法具有作为动脉样硬化心血管疾病辅助治疗的潜力,以减少残留风险.
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
481
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
481
01:16Antianginal Drugs: Nitrates and β-Blockers
564
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
564
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
505
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
505
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K